National Cancer Institute

Map of Socialist Republic of Vietnam through magnifying glass
October 6, 2016

Vanderbilt scientists to lead chronic disease research initiative in Vietnam

Scientists in the Vanderbilt Epidemiology Center (VEC) and Vanderbilt-Ingram Cancer Center (VICC) have been awarded a grant to plan and develop a Regional Center of Research Excellence in non-communicable diseases in Vietnam.

By VUMC News and Communications
October 29, 2015

Investigators find clues to melanoma treatment resistance

Nearly half of all patients with malignant melanoma, the most deadly form of skin cancer, have a mutation in the BRAF gene found in their tumors. Mutations in the BRAF gene turn on a cancer growth switch known as the MAP kinase pathway.

By VUMC News and Communications
September 17, 2015

Strong scores put VICC among top NCI centers

Vanderbilt-Ingram Cancer Center (VICC) has been recognized for the impact of its research programs and excellence in patient care by a panel of National Cancer Institute (NCI) reviewers, receiving an overall “exceptional” score as part of the renewal of the Cancer Center Support Grant (CCSG).

By VUMC News and Communications
August 13, 2015

Macara lands award to explore cancer cell behavior

Vanderbilt’s Ian Macara, Ph.D., has won an Outstanding Investigator Award from the National Cancer Institute (NCI) — nearly $6.6 million over seven years — to support the “unusual potential” of his research, which seeks to understand and predict cancer cell “behavior.”

By Bill Snyder
April 2, 2015

NCI’s national report shows cancer deaths on decline in U.S.

The death rates for most forms of cancer continue to decline at a modest pace among men, women and children in the United States, according to the Annual Report to the Nation on the Status of Cancer 1975 – 2011.

By VUMC News and Communications
March 26, 2015

Photo: Cancer discoveries

Louis Staudt, M.D., Ph.D., director of the National Cancer Institute (NCI) Center for Cancer Genomics and co-chief of the NCI’s Lymphoid Malignancies Branch, spoke about new lymphoma therapies at his recent Flexner Discovery Lecture.

By VUMC News and Communications